NCT02239081View on ClinicalTrials.gov

A Safety and Tolerability Study of CTP-730 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

CTP-730

DRUG

Placebo for CTP-730

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT02239081 - A Safety and Tolerability Study of CTP-730 in Healthy Volunteers | Biotech Hunter | Biotech Hunter